JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 4, 2005; DOI: 10.1124/jpet.105.089649


0022-3565/05/3152-553-562$20.00
JPET 315:553-562, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.089649v1
315/2/553    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salter-Cid, L. M.
Right arrow Articles by Linnik, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salter-Cid, L. M.
Right arrow Articles by Linnik, M. D.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Anti-Inflammatory Effects of Inhibiting the Amine Oxidase Activity of Semicarbazide-Sensitive Amine Oxidase

Luisa M. Salter-Cid, Eric Wang, Anne M. O'Rourke, Andrew Miller, Hongfeng Gao, Li Huang, Arnie Garcia, and Matthew D. Linnik

La Jolla Pharmaceutical Company, San Diego, California

Human semicarbazide-sensitive amine oxidase (SSAO) or vascular adhesion protein-1 (VAP-1) is a copper-containing amine oxidase (AOC3, EC 1.4.3.6) that has both enzymatic and adhesive function. SSAO catalyzes the oxidative deamination of primary amines, resulting in the formation of the corresponding aldehyde and release of hydrogen peroxide and ammonia. Membrane-bound SSAO is an inflammation-inducible endothelial cell adhesion molecule that mediates the interaction between leukocytes and activated endothelial cells in inflamed vessels. Both the direct adhesive and enzymatic functions seem to be involved in the adhesion cascade. LJP 1207 [N'-(2-phenyl-allyl)-hydrazine hydrochloride] is a potent (human SSAO IC50 = 17 nM), selective, and orally available SSAO inhibitor that blocks both the enzymatic and adhesion functions of SSAO/VAP-1. In a mouse model of ulcerative colitis, LJP 1207 significantly reduces mortality, loss of body weight, and colonic cytokine levels. Quantitative histopathological assessment of colitis activity in this model showed a highly significant suppression of inflammation, injury, and ulceration scores in the animals treated with the SSAO/VAP-1 inhibitor. LJP 1207 also reduced serum levels of tumor necrosis factor-{alpha} and interleukin 6 in lipopolysaccharide (LPS)-challenged mice and prolonged survival post-LPS-induced endotoxemia. Therapeutic and prophylactic administration of LJP 1207 in the rat carrageenan footpad model also markedly inhibited swelling and inflammation. Overall, the data suggest that small molecule SSAO/VAP-1 inhibitors may provide clinical benefit in the treatment of acute and chronic inflammatory diseases.


Received May 20, 2005; accepted August 2, 2005.

Address correspondence to: Dr. Matthew D. Linnik, La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, CA 92121. E-mail: matthew.linnik{at}ljpc.com




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. O'Rourke, E. Y. Wang, A. Miller, E. M. Podar, K. Scheyhing, L. Huang, C. Kessler, H. Gao, H.-T. Ton-Nu, M. T. MacDonald, et al.
Anti-Inflammatory Effects of LJP 1586 [Z-3-Fluoro-2-(4-methoxybenzyl)allylamine Hydrochloride], an Amine-Based Inhibitor of Semicarbazide-Sensitive Amine Oxidase Activity
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 867 - 875.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Weissen-Plenz, A. Hoffmeier, and J. R. Sindermann
Lysyl Oxidase Inhibition Is Responsible for the Vascular Elastic Fiber Phenotype
Hypertension, February 1, 2008; 51(2): e13 - e13.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jalkanen and M. Salmi
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 18 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Koskinen, S. Nevalainen, M. Karikoski, A. Hanninen, S. Jalkanen, and M. Salmi
VAP-1-Deficient Mice Display Defects in Mucosal Immunity and Antimicrobial Responses: Implications for Antiadhesive Applications
J. Immunol., November 1, 2007; 179(9): 6160 - 6168.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Salmi and S. Jalkanen
Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans
Blood, September 1, 2006; 108(5): 1555 - 1561.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-L. Xu, L. Salter-Cid, M. D. Linnik, E. Y. Wang, C. Paisansathan, and D. A. Pelligrino
Vascular Adhesion Protein-1 Plays an Important Role in Postischemic Inflammation and Neuropathology in Diabetic, Estrogen-Treated Ovariectomized Female Rats Subjected to Transient Forebrain Ischemia
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 19 - 29.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.